Brello Health Review 2026: GLP-1 Program, Pricing, Eligibility, and Support
By Gabi Thompson
Health & Personal CareAffiliate Disclosure: We may earn a commission from qualifying links in this article. This does not affect the price you pay.
Medical Note: This article provides general information and is not medical advice. Treatment suitability, prescribing decisions, risks, and medication choices should be discussed with a qualified healthcare professional.
Starting a GLP-1 program online should feel clear, not confusing. The medication itself is only one part of the decision. Provider access, upfront cost, renewal timing, supplies, digital support, refund rules, and the status of compounded medications all shape the experience.
This Brello Health review looks closely at how the online Brello GLP-1 program works, including its compounded semaglutide and tirzepatide options, what each plan currently includes, how much they cost, and what happens before medication is prescribed.
Brello brings plan selection, provider review, fulfillment if approved, and ongoing digital support into one online process. Medication is dispensed only after a healthcare provider reviews the customer's information and issues a valid prescription when appropriate.
Brello Health Review: The Quick Take
See what Brello brings together before comparing its two featured GLP-1 plans.
Customers purchase a plan first, then complete the medical intake through their telehealth account. A healthcare provider reviews the information and determines if treatment is appropriate. Approval is not automatic, and medication is supplied only if a prescription is issued.
Current plan benefits include:
- Provider health review
- Prescribed medication if approved
- Syringes and injection instructions
- Unlimited provider messaging
- Brello App access
- Brello Rise virtual fitness and nutrition classes
- Private community access
- Shipping after approval
Brello's featured GLP-1 options use compounded medications. These products are not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Review the Brello GLP-1 program and see what each plan includes.
What Is the Brello GLP-1 Program?
Bring provider review, fulfillment if prescribed, and ongoing support into one digital process with Brello.
The platform connects customers with healthcare providers through telehealth. After purchase and medical intake, a provider reviews the submitted information and decides if the selected plan is appropriate.
If approved, Brello's current plans include medication, syringes with needles, injection instructions, provider messaging, access to the Brello App, Brello Rise fitness and nutrition classes, and its private Facebook community.
Brello states that approved treatment is compounded through a U.S.-based 503(a) pharmacy. It also currently promotes the same subscription price across dose levels.
The two featured three-month GLP-1 plans are:
Medication selection and dosing remain provider decisions based on the individual's medical information.
Explore Brello's GLP-1 plans and compare the current program options.
How Does Brello Health Work?
Follow a straightforward online path from plan selection to provider review.
1. Select and Purchase a Plan
Choose the semaglutide or tirzepatide option and complete checkout.
2. Complete the Medical Intake
After paying, complete the online intake inside the telehealth account. Brello specifically states that no intake form is required before purchase.
3. Receive a Provider Review
A healthcare provider reviews the submitted health information to decide if the plan is appropriate. Accurate medical and medication information matters because prescribing decisions rely on those details.
4. Receive the Kit If Approved
If approved, the prescribed medication, supplies, and instructions are prepared for shipment.
Brello's main GLP-1 page currently estimates shipping within 3–5 business days after approval in most states. Because fulfillment conditions can change, check the live page before relying on a specific delivery window.
If the provider determines that treatment is not appropriate and no prescription is issued, Brello currently provides a full refund.
Start with Brello's current GLP-1 plan and eligibility process.
Brello Semaglutide Plan
Consider the Brello compounded semaglutide with B6 plan when comparing the platform's two primary three-month GLP-1 options.
The current plan costs $399 upfront. Brello presents that as an average of $133 per month, but customers are billed the full $399 at checkout rather than $133 monthly.
After the initial term, the subscription renews for $399 every 11 weeks until canceled.
If approved, the plan includes:
- Compounded semaglutide
- Syringes with needles
- Injection instructions
- Provider health review
- Brello App access
- Brello Rise fitness and nutrition classes
- Private Facebook community
- Ongoing support
Brello also advertises the same plan price across dose levels. The prescribing healthcare provider should determine dosage, not the price.
The compounded semaglutide supplied through the program is not FDA-approved and is not an FDA-approved generic equivalent.
Review Brello's compounded semaglutide plan.
Brello Tirzepatide Plan
Compare the Brello compounded tirzepatide with B6 plan separately instead of treating it as interchangeable with semaglutide.
The current three-month subscription costs $499 upfront, which Brello presents as an average of $166 per month. The full amount is billed at checkout.
The plan then renews for $499 every 11 weeks until canceled.
Current inclusions are similar to the semaglutide plan:
- Compounded tirzepatide if prescribed
- Syringes and injection instructions
- Provider health review
- Brello App access
- Brello Rise classes
- Private community access
- Ongoing provider support
Brello currently keeps the advertised subscription price the same across dose levels.
Price should not decide which medication, if any, is prescribed. Medical history, current medications, potential risks, contraindications, and provider judgment are more important considerations.
The tirzepatide offered through this plan is compounded and is not FDA-approved.
Review Brello's compounded tirzepatide plan.
Brello Semaglutide vs. Tirzepatide
Compare the subscription structure while leaving medication selection to the provider.
|
Plan Detail
|
Brello Semaglutide
|
Brello Tirzepatide
|
|---|---|---|
|
Initial charge
|
$399
|
$499
|
|
Advertised monthly average
|
$133
|
$166
|
|
Initial plan length
|
3 months
|
3 months
|
|
Renewal
|
$399 every 11 weeks
|
$499 every 11 weeks
|
|
Medication
|
If prescribed
|
If prescribed
|
|
Provider review
|
Included
|
Included
|
|
Injection supplies
|
Included
|
Included
|
|
Digital support
|
Included
|
Included
|
Brello's checkout terms confirm the current $399 semaglutide and $499 tirzepatide three-month rates, with renewal every 11 weeks at the same respective price.
The pricing difference is useful for budgeting, but clinical suitability should drive the medication decision.
Compare Brello's semaglutide and tirzepatide plans side by side.
Brello Eligibility: Who May Qualify?
Complete the intake accurately and let the reviewing healthcare provider determine suitability.
Brello does not currently publish a full public Brello eligibility checklist that lets customers approve themselves for treatment. Instead, the process relies on an online medical intake followed by provider review.
Customers should be prepared to provide:
- Relevant medical history
- Current medications
- Previous medication use
- Other information requested during intake
Brello's checkout terms emphasize accurate medical information because providers rely on it when making prescribing decisions.
A valid prescription is required before medication is dispensed. Approval is not guaranteed, and availability can vary by location.
If the provider determines that a customer is not an appropriate candidate and no prescription is issued, Brello's current refund policy provides a full refund.
Review Brello's current eligibility and provider-review process.
Brello Health Pricing and Renewal Terms
Look beyond the monthly average and focus on the actual billing schedule.
Current Brello Health pricing for the featured three-month plans is:
- Compounded semaglutide: $399 upfront
- Compounded tirzepatide: $499 upfront
Each subscription currently renews every 11 weeks at the same rate as the initial charge. Customers can stop future renewals through their online account. Brello says cancellations should be completed at least two business days before the next billing date to avoid the next charge.
Refund timing changes once the provider review is complete.
Cancel before the health review, or receive a decision that you are not an appropriate candidate without a prescription being issued, and Brello currently provides a full refund.
If a prescription has been written but the medication has not yet been dispensed, Brello may refund the amount paid minus a $50 professional service fee if you submit the request within 24 hours of the completed-review notice. Dispensed medication is non-refundable under the current policy.
Check Brello's current plans, billing schedule, and terms before enrolling.
Important Limitations to Know
Know what the program does and does not promise before moving forward.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or quality before marketing, and they are not the same as FDA-approved generic drugs.
FDA has also cautioned telehealth companies against marketing compounded GLP-1 products as FDA-approved, equivalent to approved drugs, or clinically proven to produce the same results.
Other points to keep in mind:
- A valid prescription is required.
- A healthcare provider determines suitability.
- Approval is not guaranteed.
- Individual outcomes differ.
- State availability can change.
- Fulfillment timing can change.
- Dosing decisions belong to the prescriber.
- Potential risks, side effects, contraindications, and alternatives should be discussed with a healthcare professional.
The online process adds convenience, but clinical decisions still belong in the provider-patient relationship.
Brello Health Frequently Asked Questions
Does Brello require a prescription?
Yes. Medication is supplied only after a healthcare provider reviews the submitted information and issues a prescription when appropriate.
Is medication included in the plan?
Brello states that prescribed medication, syringes, and injection instructions are included if treatment is approved.
Do customers complete the intake before paying?
No. Brello currently requires customers to purchase a plan first and complete the online medical intake after checkout.
What happens if treatment is not approved?
If the provider determines that the customer is not an appropriate candidate and no prescription is issued, Brello's refund policy currently provides a full refund.
Explore Brello's latest GLP-1 program details before choosing a plan.
Look at the complete experience rather than judging Brello by the medication price alone.
The Brello GLP-1 program packages provider review, medication if prescribed, injection supplies, ongoing messaging, app access, virtual fitness and nutrition resources, and community support into one online subscription.
Its current Brello semaglutide and Brello tirzepatide plans also make the billing structure easy to understand upfront: each starts with a three-month plan and renews every 11 weeks at its respective rate.
The trade-offs deserve the same attention. These are compounded medications, provider approval is required, subscriptions renew automatically until canceled, and refund options narrow after a prescription is issued and medication is dispensed.
For someone researching online GLP-1 care, Brello stands out most for bringing the medical review, fulfillment if approved, supplies, and ongoing digital support under one program. The next step is not choosing a medication on your own. It is reviewing the terms carefully and letting a healthcare provider determine if treatment is appropriate for you.
Explore Brello's current GLP-1 plans and begin the provider-led eligibility process.